SPEAKER INDEX CONTENTS INSERTS
APPEAL OF DETERMINATIONS OF THE COMMISSIONER 18
APPLICATION FEE 18
BERDON 98 166 172
BERMAN 21 30 66 157 158 161 162 163 164
170 171 172 173 180 181 182 183 185
186 238 239 240 241 242 245 246 247
248
BERRY 60
BINDER 190 192 236 237 242 244 245 246 247
248
BLAINE MERRITT 4
BLUNT 13
BONO 13
BRYANT 13 29 36 42 66
BURGOON 219 238 243 244
CANNON 175 176 177 178 179
COBLE 10 11 12 20 24 27 28 29 30
35 36 42 48 60 66 67 69 84
98 112 124 130 141 144 153 154 155
156 157 159 164 166 167 169 170 171
172 173 174 175 179 180 183 186 187
190 191 192 203 219 235 236 237 238
242 245 249
COMPENSATION 19
CONYERS 13 27
COURT JURISDICTION 18
CUNNINGHAM 10 11
DEAR CHAIRMAN COBLE 110 168 265
DEAR JOHN 82
DEAR MR. ANSELL 80
DEAR MR. BINDER 249
DEAR MR. CHAIRMAN 261 263
DEAR ORRIN 159
DEAR PETER 83
DEAR REPRESENTATIVE DELAHUNT 255
DEAR SENATOR HATCH 151
DEBBIE K. LAMAN 4
DEFINITIONS 14
DELAHUNT 13 24
DOWNEY 67 84 165 182
DUNCAN 13
EFFECT OF FILING OF ABBREVIATED APPLICATIONS 19
EFFECTIVE DATE 20
EMERSON 13
ESHOO 13
EUNICE GOLDRING 4
FILING AND DETERMINATION 16
FORD 13
FRANKS 13
FREDERICK S. ANSELL, ESQUIRE 80
FRELINGHUYSEN 13
GALLEGLY 173 174 187 242 243 244 245
GOODLATTE 174 175
GORDON 13
GORDON M. BINDER 249
HENRY J. HYDE 167
HILLEARY 13
HOWARD COBLE 110 260 262 265
HOYER 13
HUTT 70 156 157 158 162 163 164 174 175
180 181 182 184 185
IN GENERAL 14 19
INFRINGEMENT 16
INTERIM RESTORATION 17
JACKSON-LEE 13
JENKINS 13
JOHN P. MCLAUGHLIN, ESQUIRE 82
JULIAN EPSTEIN 3
KEALEY 130 167 169 170
LEHMAN 69 124 155 158 183
LIMITS ON LIABILITY 19
MCDERMOTT 13 42
MENENDEZ 13
MEYER 141 155 176 177
MITCH GLAZIER 4
ORR 144 179
ORRIN G. HATCH 159
ORRIN HATCH 151
PASTOR 13
PATENT TERM RESTORATION 13
PAYNE 13
PETER BARTON HUTT 83
PROCEDURE 16
RECORD 17
RECORDS 15
REPORT 20
RESTORATION TERM 15
ROBERT RABEN 4
ROTHMAN 13
SELDEN 203 235 237 238 239 240 241 248
SMITH 13
SPECIAL PATENT TERM REVIEW PROCEDURE 14
SPICEHANDLER 112 154 177 178 184
ST SESSION 13
STANDARDS 14
TAUSCHER 13
TECHNICAL AND CONFORMING AMENDMENT 18
TH CONGRESS 13
THOMAS E. MOONEY, SR 3
TIME FOR FILING 16
TORRICELLI 29 30 35
VINCE GARLOCK 4
WAMP 13
WAXMAN 48 49
WICKER 13
WILLIAM DELAHUNT 255
CONTENTS SPEAKERS INSERTS
OPENING STATEMENT OF CHAIRMAN COBLE
PAGE 10
STATEMENT OF HON. ROBERT G. TORRICELLI, A U.S. SENATOR FROM THE STATE OF NEW JERSEY
PAGE 29
STATEMENT OF HON. ED BRYANT, A REPRESENTATIVE IN CONGRESS FROM THE STATE OF TENNESSEE
PAGE 36
STATEMENT OF HON. JIM MCDERMOTT, A REPRESENTATIVE IN CONGRESS FROM THE STATE OF WASHINGTON
PAGE 42
STATEMENT OF HON. HENRY A. WAXMAN, A REPRESENTATIVE IN CONGRESS FROM THE STATE OF CALIFORNIA
PAGE 48
STATEMENT OF HON. MARION BERRY, A REPRESENTATIVE IN CONGRESS FROM THE STATE OF ARKANSAS
PAGE 60
STATEMENT OF PETER BARTON HUTT, PARTNER, COVINGTON AND BURLING
PAGE 70
STATEMENT OF BRUCE L. DOWNEY, CHAIRMAN, CEO, AND PRESIDENT, BARR LABORATORIES
PAGE 84
STATEMENT OF ANDREW M. BERDON, VICE PRESIDENT AND GENERAL COUNSEL, PUREPAC PHARMACEUTICAL COMPANY,
ON BEHALF OF THE COALITION FOR AFFORDABLE PHARMACEUTICALS
PAGE 98
STATEMENT OF JONATHAN R. SPICEHANDLER, M.D., PRESIDENT, SCHERING-PLOUGH RESEARCH INSTITUTE
PAGE 112
STATEMENT OF BRUCE LEHMAN, PRESIDENT AND CEO, INTERNATIONAL INTELLECTUAL PROPERTY INSTITUTE
PAGE 124
STATEMENT OF MAURA KEALEY, DEPUTY DIRECTOR, PUBLIC CITIZEN'S CONGRESS WATCH
PAGE 130
STATEMENT OF GERALD F. MEYER, SENIOR CONSULTANT, AAC CONSULTING GROUP, INC.
PAGE 141
STATEMENT OF WILLIAM ORR, CHAIRMAN, NATIONAL ALTERNATIVE FUELS ASSOCIATION
PAGE 144
STATEMENT OF GORDON BINDER, CEO, AMGEN
PAGE 190
STATEMENT OF RICHARD SELDEN, M.D., CEO, TRANSKARYOTIC THERAPIES, INC. (TRT)
PAGE 203
STATEMENT OF RICHARD P. BURGOON, JR., VICE PRESIDENT, GENERAL COUNSEL, AND ASSISTANT SECRETARY,
ARENA PHARMACEUTICALS, INC.
PAGE 219
INSERTS SPEAKERS CONTENTS